Magic Hour
You are here:  Home  >  Biotech  >  Current Article

Cure Pharmaceuticals may double shares of common stock

By   /   Friday, June 14th, 2019  /   Comments Off on Cure Pharmaceuticals may double shares of common stock

    Print       Email
Cure Pharmaceuticals shareholders will vote on a proposal to double the company’s shares of common stock from 75 million to 150 million and its common stock available for awards from 5 million to 10 million at its 2019 annual shareholders meeting on July 15 in Oxnard. In a pre-proxy statement filed after markets closed June…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Carpinteria-based Procore Technologies moved up from No. 880 last year to No. 697 this year. (Nik Blaskovich)

Procore announces second recent acquisition

Read More →